PVLA (Pieris Pharmaceuticals) Short-Term Debt to Capital
The price action of Pieris Pharmaceuticals (PVLA), where the metric reaches 0.01, indicates a phase of deep asset reassessment and a search for new allies. The business relies on unique protein developments protected by patents from market pressure. The company's success is based on creating advanced treatments for cancer and lung diseases through close collaboration with global medical leaders.
Analytical breakdowns for Pieris Pharmaceuticals
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Pieris Pharmaceuticals|PVLA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Pieris Pharmaceuticals, Inc.|PVLA - Aggregate Debt Obligations|Debts to Book Capitalization Pieris Pharma|PVLA - Long-Term Debt Volume|Company Short-Term Debt Pieris Pharmaceuticals|Quick Liquidity pieris.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Pieris Pharmaceuticals Inc
Amid the restructuring of protein drugs and the loss of partners, the short-term debt to equity ratio on the GURU.Markets platform reflects Pieris Pharmaceuticals (PVLA) critical dependence on short-term borrowed capital. This metric compares obligations with a maturity of up to one year against total equity, revealing hidden liquidity risks between quarterly reports, which underscores the asset's high speculativeness.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV - Short-Term Debt to Equity|Current Liabilities to Equity SEPN|SVRA: Short-Term Debt to Capital|RIGL - Short-Term Debt to Capital Coefficient|ANAB (AnaptysBio) - Short-Term Debt to Capital|Current Liabilities to Capital Astria Therapeutics Inc ATXS|Short-Term Debt to Equity enGene Bio (ENGN)|RAPT (rapt.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital JBIO (Aerovate Therapeutics)|Short-Term Debt to Capital Coefficient aclaristx.com (ACRS)|KYTX - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Tiziana Life Sciences Ltd. TLSA|CABA (Cabaletta Bio, Inc) - Short-Term Debt to Equity Ratio|Ventyx Biosciences, Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Theratechnologies Inc.|avalotx.com - Current Liabilities to Equity|Short-Term Debt to Capital ELDN|AGEN (Agenus, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|Short-Term Debt to Capital zurabio.com ZURA|ATYR - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ADAG (Adagene)|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Shattuck Labs|EQ (Equillium Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Connect Pharma|Short-Term Debt to Capital IMUX|Short-Term Debt to Equity Ratio atarabio.com ATRA|Short-Term Debt to Capital IFRX (InflaRx)|X4 Pharmaceuticals Inc. (XFOR) - Current Liabilities to Capital|ACET: Short-Term Debt to Equity Ratio|CELU - Short-Term Debt to Capital|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|BRNS: Short-Term Loans to Capital Ratio|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|SAB Biotherapeutics Inc. (SABS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital AKTX|Short-Term Debt to Equity Ratio enlivex.com ENLV|Short-Term Debt to Capital QTTB (Q32 Bio)|Short-Term Debt to Capital geovax.com GOVX|EDSA - Short-Term Debt to Equity|IBIO: Short-Term Debt to Equity|carismatx.com (CARM) - Short-Term Debt to Equity|XTLB - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCW Biologics Inc - Current Liabilities to Equity|Short-Term Debt to Equity Ratio APVO (Aptevo Therapeutics)|Short-Term Debt to Equity AIM (aimimmuno.com)|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI Bio Corporation - Short-Term Debt to Equity|XORTX Therapeutics Inc. - Short-Term Debt to Capital|HIND - Short-Term Debt to Capital|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Current Liabilities to Equity INDP (Indaptus Therapeutics Inc)|SCNI (Scinai) - Short-Term Debt to Capital|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital allakos.com (ALLK)|Short-Term Debt to Equity HOOKIPA Pharma HOOK|Ratio of Short-Term Indebtedness to Capital IGMS|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TCBP: Short-Term Debt to Capital|thirdharmonicbio.com (THRD) - Short-Term Debt to Capital